These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 26542377)

  • 21. Insulin resistance and cardiovascular risk: New insights from molecular and cellular biology.
    Morisco C; Lembo G; Trimarco B
    Trends Cardiovasc Med; 2006 Aug; 16(6):183-8. PubMed ID: 16839860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial.
    Atkin M; Laight D; Cummings MH
    J Diabetes Complications; 2016; 30(4):723-7. PubMed ID: 26954484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Insulin resistance, metabolic syndrome and cardiovascular diseases].
    Zeman M; Zák A; Vecka M; Tvrzická E
    Cas Lek Cesk; 2005; 144 Suppl 1():19-20, 22-6. PubMed ID: 15981981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiovascular disease in diabetes mellitus: classical and non-classical risk factors].
    Siqueira AF; Almeida-Pititto Bd; Ferreira SR
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):257-67. PubMed ID: 17505632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance and the endothelium.
    Quiñones MJ; Nicholas SB; Lyon CJ
    Curr Diab Rep; 2005 Aug; 5(4):246-53. PubMed ID: 16033673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance and cardiovascular disease.
    Kosmas CE; Bousvarou MD; Kostara CE; Papakonstantinou EJ; Salamou E; Guzman E
    J Int Med Res; 2023 Mar; 51(3):3000605231164548. PubMed ID: 36994866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why does obesity increase the risk for cardiovascular disease?
    Boden G; Salehi S
    Curr Pharm Des; 2013; 19(32):5678-83. PubMed ID: 23448485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes mellitus: a cardiovascular disease.
    Candido R; Srivastava P; Cooper ME; Burrell LM
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1088-94. PubMed ID: 14582453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients.
    Forst T; Hohberg C; Pfützner A
    Horm Metab Res; 2009 Feb; 41(2):123-31. PubMed ID: 19214922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin Signal Transduction Perturbations in Insulin Resistance.
    Khalid M; Alkaabi J; Khan MAB; Adem A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cocoa, glucose tolerance, and insulin signaling: cardiometabolic protection.
    Grassi D; Desideri G; Mai F; Martella L; De Feo M; Soddu D; Fellini E; Veneri M; Stamerra CA; Ferri C
    J Agric Food Chem; 2015 Nov; 63(45):9919-26. PubMed ID: 26126077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the adverse cardiovascular prognosis of type 2 diabetes.
    O'Keefe JH; Miles JM; Harris WH; Moe RM; McCallister BD
    Mayo Clin Proc; 1999 Feb; 74(2):171-80. PubMed ID: 10069357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.